| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $795K | -46.9% | — |
| R&D Expense | $9.4M | -9.5% | -3.6% |
| SG&A Expense | $4.6M | +9.9% | +20.5% |
| Operating Income | -$13.7M | -4.8% | -1.0% |
| Income Tax | $0 | — | — |
| Net Income | -$15.1M | -20.0% | -12.0% |
| EPS (Basic) | -$0.55 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $75.3M | +92.7% | +2876.9% |
| Current Assets | $77.7M | +89.1% | +1311.8% |
| Total Assets | $86.4M | +68.5% | +304.4% |
| Current Liabilities | $7.9M | +7.7% | -33.2% |
| Total Liabilities | $27.7M | +145.6% | +52.4% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$35.8M | — | — |
| Capital Expenditures | $279K | — | — |
| Investing Cash Flow | -$243K | — | — |
| Financing Cash Flow | $47.3M | — | — |
| Free Cash Flow | -$36.1M | — | — |
| +97.7% |
| EPS (Diluted) | -$0.55 | +11.3% | +97.7% |
| $58.7M |
| +46.7% |
| +136.9% |